查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386408

臨床前體內影像市場報告：2030 年趨勢、預測與競爭分析

Preclinical In-Vivo Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

臨床前體內影像的趨勢與預測

到 2030 年，全球臨床前體內影像市場預計將達到 14 億美元，2024 年至 2030 年複合年成長率為 6.2%。該市場的主要促進因素是慢性病盛行率的增加、對侵入性小動物成像技術的需求不斷成長以及臨床前研究活動資金的增加。全球臨床前體內影像市場的未來充滿希望，研發和藥物研發市場充滿機會。

臨床前體內成像市場洞察

Lucintel 預測，微超音波系統將在預測期內達到最高成長。

由於擴大採用研究和藥物研發模式，研究和開發仍然是市場中最大的部分。

由於加拿大臨床前研究量的增加以及政府對研究和創新的資助的增加，北美仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個區隔市場成長較快？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球臨床前體內影像市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球臨床前體內影像市場趨勢（2018-2023）與預測（2024-2030）
  • 依類型分類的全球臨床前體內影像市場
    • 光學成像
    • 核子造影
    • MRI顯影劑
    • 超音波顯影劑
    • CT顯影劑
  • 依模式分類的全球臨床前體內影像市場
    • 光學成像系統
    • 臨床前核子造影系統
    • 微型核磁共振系統
    • 微超音波系統
    • 顯微CT系統
    • 臨床前光聲成像系統
    • 臨床前磁粒子成像 (MPI) 系統
  • 依應用分類的全球臨床前體內影像市場
    • 研究與開發
    • 藥物研發
  • 依配銷通路分類的全球臨床前體內影像市場
    • 製藥公司
    • 生技公司
    • 研究機構
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球臨床前體內影像市場（依地區）
  • 北美臨床前體內影像市場
  • 歐洲臨床前體內影像市場
  • 亞太地區臨床前體內影像市場
  • 其他區域臨床前體內影像市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依類型分類的全球臨床前體內成像市場成長機會
    • 依方式分類的全球臨床前體內影像市場成長機會
    • 全球臨床前體內影像市場成長機會（依應用）
    • 依配銷通路分類的全球臨床前體內成像市場成長機會
    • 依地區分類的全球臨床前體內成像市場成長機會
  • 全球臨床前體內影像市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球臨床前體內影像市場的能力
    • 全球臨床前體內影像市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Bruker Corporation
  • Siemens
  • TriFoil Imaging
  • PerkinElmer
  • VisualSonics
簡介目錄

Preclinical In-Vivo Imaging Trends and Forecast

The future of the global preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets. The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

A more than 150-page report is developed to help in your business decisions.

Preclinical In-Vivo Imaging by Segment

The study includes a forecast for the global preclinical in-vivo imaging by type, modality, application, distribution channel, and region.

Preclinical In-Vivo Imaging Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Optical Imaging
  • Nuclear Imaging
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • CT Contrast Agents

Preclinical In-Vivo Imaging Market by Modality [Shipment Analysis by Value from 2018 to 2030]:

  • Optical Imaging Systems
  • Preclinical Nuclear Imaging Systems
  • Micro-MRI Systems
  • Micro-Ultrasound Systems
  • Micro-CT Systems
  • Preclinical Photoacoustic Imaging Systems
  • Preclinical Magnetic Particle Imaging (MPI) Systems

Preclinical In-Vivo Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Research & Development
  • Drug Discovery

Preclinical In-Vivo Imaging Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Institutes
  • Others

Preclinical In-Vivo Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Preclinical In-Vivo Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preclinical in-vivo imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preclinical in-vivo imaging companies profiled in this report include-

  • Bruker Corporation
  • Siemens
  • Trifoil Imaging
  • Perkinelmer
  • Visualsonics

Preclinical In-Vivo Imaging Market Insights

Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.

Within this market, research & development will remain the largest segment due to the increased adoption of modalities for research and drug development.

North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Features of the Global Preclinical In-Vivo Imaging Market

Market Size Estimates: Preclinical in-vivo imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Preclinical in-vivo imaging market size by various segments, such as by type, modality, application, distribution channel and region in terms of ($B).

Regional Analysis: Preclinical in-vivo imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, modalities, applications, distribution channels, and regions for the preclinical in-vivo imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preclinical in-vivo imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the preclinical in-vivo imaging market size?

Answer: The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for preclinical in-vivo imaging market?

Answer: The global preclinical in-vivo imaging market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the preclinical in-vivo imaging market?

Answer: The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

Q4. What are the major segments for preclinical in-vivo imaging market?

Answer: The future of the preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets.

Q5. Who are the key preclinical in-vivo imaging market companies?

Answer: Some of the key preclinical in-vivo imaging companies are as follows:

  • Bruker Corporation
  • Siemens
  • TriFoil Imaging
  • PerkinElmer
  • VisualSonics

Q6. Which preclinical in-vivo imaging market segment will be the largest in future?

Answer: Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.

Q7. In preclinical in-vivo imaging market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the preclinical in-vivo imaging market by type (optical imaging, nuclear imaging, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), modality (optical imaging systems, preclinical nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems), application (research & development and drug discovery), distribution channel (pharmaceutical companies, biotechnology companies, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Preclinical In-Vivo Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Preclinical In-Vivo Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Preclinical In-Vivo Imaging Market by Type
    • 3.3.1: Optical Imaging
    • 3.3.2: Nuclear Imaging
    • 3.3.3: MRI Contrast Agents
    • 3.3.4: Ultrasound Contrast Agents
    • 3.3.5: CT Contrast Agents
  • 3.4: Global Preclinical In-Vivo Imaging Market by Modality
    • 3.4.1: Optical Imaging Systems
    • 3.4.2: Preclinical Nuclear Imaging Systems
    • 3.4.3: Micro-MRI Systems
    • 3.4.4: Micro-Ultrasound Systems
    • 3.4.5: Micro-CT Systems
    • 3.4.6: Preclinical Photoacoustic Imaging Systems
    • 3.4.7: Preclinical Magnetic Particle Imaging (MPI) Systems
  • 3.5: Global Preclinical In-Vivo Imaging Market by Application
    • 3.5.1: Research & Development
    • 3.5.2: Drug Discovery
  • 3.6: Global Preclinical In-Vivo Imaging Market by Distribution Channel
    • 3.6.1: Pharmaceutical Companies
    • 3.6.2: Biotechnology Companies
    • 3.6.3: Research Institutes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Preclinical In-Vivo Imaging Market by Region
  • 4.2: North American Preclinical In-Vivo Imaging Market
    • 4.2.1: North American Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
    • 4.2.2: North American Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
  • 4.3: European Preclinical In-Vivo Imaging Market
    • 4.3.1: European Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
    • 4.3.2: European Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
  • 4.4: APAC Preclinical In-Vivo Imaging Market
    • 4.4.1: APAC Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
    • 4.4.2: APAC Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
  • 4.5: ROW Preclinical In-Vivo Imaging Market
    • 4.5.1: ROW Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
    • 4.5.2: ROW Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Type
    • 6.1.2: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Modality
    • 6.1.3: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Application
    • 6.1.4: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Region
  • 6.2: Emerging Trends in the Global Preclinical In-Vivo Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Preclinical In-Vivo Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preclinical In-Vivo Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bruker Corporation
  • 7.2: Siemens
  • 7.3: TriFoil Imaging
  • 7.4: PerkinElmer
  • 7.5: VisualSonics